NFE2L2 and neoplasm: The potential use of NRF2 pathway modulators for cancer prevention or treatment remains a controversial topic and the safety of NRF2 activating drugs for non-cancer diseases has been questioned due to the potential effects of NRF2 activation in tumor cells, namely drug resistance and increased survival [24].